AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week

The global "AI in drug discovery" market was worth $1.1B last year and is expected to expand by a CAGR of 30% between now and 2030 leading to 50 novel therapies over the next decade, with annual sales in excess of $50 billion